[Pr]From Non-curable to Curable Neurology－Elucidation of the Pathophysiology of Neurological Diseases and Molecular Targeted Therapy－
Tatsushi Toda(Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan)
Neuro65/AOCN2024
May 29 - Jun 1, 2024Tokyo International Forum
You can search for presentations in this event.
Search
Neuro65/AOCN2024
May 29 - Jun 1, 2024Tokyo International Forum
You can search for presentations in this event.
SearchSearch Results(1,853)
[Vpr]Development of heteroduplex oligonucleotide (HDO), a Novel Nucleic Acid Medicine
Takanori Yokota(Professor of Department of Neurology and Neurological Science, Tokyo Medical and Dental University / Director of NucleoTIDE and PepTIDE Drug Discovery Center, Japan)
[AW-1]Clarifying the role of neuroinflammation by microglia and macrophages in neurological diseases
Ryo Yamasaki(Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan)
[PL-01-1]Mechanistic Insights and Therapeutic Approaches to Restore Muscle Function in Muscular Dystrophy
Kevin Campbell1,2(1.University of Iowa, USA, 2.Howard Hughes Medical Institute, USA)
[PL-02-1]Asian and Oceanian Association of Neurology (AOAN), the past, the present and the future
Hj Hamidon Basri1,2(1.AOAN President, Malaysia, 2.Director Hospital Sultan Abdul Aziz Shah UPM, Malaysia)
[PL-03-1]40 years from genetics, genomics, cancer genomics and immunogenomics to AI
Yusuke Nakamura(National Institutes of Biomedical Innovation, Health and Nutrition, Japan)
[WA-1]The WHO Intersectoral Action Plan for Epilepsy and other neurological disorders (IGAP)
Wolfgang Grisold1, Alla Guekht2, Steven Lewis2(1.President World Federation of Neurology (WFN), UK, 2.World Federation of Neurology, UK)
[WA-2]World Health Organization (WHO)'s Intersectoral Global Action Plan (IGAP) and Asia pacific region
Mohammad Wasay(Elected trustee, WFN, Pakistan)
[WA-3]African neurology and the IGAP; harnessing all efforts to improve access to neurological care
Augustina Charway-Felli(African Academy of Neurology, Ghana)
[WA-4]NEUROLOGY IN MONGOLIA
Sarangerel Jambal(President Mongolian Neurological Society, Mongolia)
[WA-5]Advancing Brain Health for All: A Call to Action in the Asia Oceania Region
Tissa Wijeratne1,2,3,4,5(1.La Trobe University, RMIT, VU, Australia, 2.Migraine Foundation, Australia, 3.World Federation of Neurology, UK, 4.Western Health, Australia, 5.University of Rajarata, Sri Lanka)
[NFS-01-1]Progress towards interventional neurogenetics
Timothy Yu1,2(1.Division of Genetics and Genomics, Boston Children's Hospital, USA, 2.Harvard Medical School, USA)
[NFS-01-2]Developing a new HDO technology using morpholino oligomer to regulate gene expression
Tetsuya Nagata1,2(1.NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University, Japan, 2.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan)
[NFS-01-3]Establishing siRNA strategies for a single gene- or a single nucleotide-specific RNA interference
Kumiko Ui-Tei(Graduate School of Science, The University of Tokyo, Japan)
[NFS-01-4]Invention of an oral medication for genetic disorders caused by mis-splicing
Masatoshi Hagiwara(Department of Anatomy and Developmental Biology, Kyoto University Graduate School of Medicine, Japan)
[NFS-02-1]Introduction of research on PD pathogenesis
Shinji Saiki(Department of Neurology, Institute of Medicine, University of Tsukuba, Japan)
[NFS-02-2]The main stream "alpha-synuclein pathology"
Ayami Okuzumi1, Taku Hatano1, Gen Matsumoto2, Nobutaka Hattori1,3(1.Department of Neurology, Faculty of Medicine, Juntendo University, Japan, 2.Department of Histology and Cell Biology, Nagasaki University School of Medicine, Japan, 3.Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, Japan)
[NFS-02-3]Molecular mechanisms of mitochondria quality control and mitophagy underlying PD pathogenesis
Noriyuki Matsuda(Dept. Biomolecular Pathogenesis, Medical Research Inst., Tokyo Medical and Dental Univ., Japan)
[NFS-02-4]Autophagy as a guardian against ageing and age-related neurodegeneration
Viktor I. Korolchuk(Newcastle University, Biosciences Institute, Ageing Research, UK)
[NFS-03-1]Biomarkers for Neurodegenerative Diseases
Ruben Smith(Lund University, Sweden)
[NFS-03-2]Parkinson's and Alzheimer's disease Dimensional Neuroimaging Initiative (PADNI)
Takashi Hanakawa(Kyoto University Graduate School of Medicine, Japan)
[NFS-03-3]Development of a Novel Plasma p-Tau181 Assay Reflecting Tau Tangle Pathology in Alzheimer's Disease
Kenji Tagai, Harutsugu Tatebe, Makoto Higuchi, Takahiko Tokuda(National Institutes for Quantum and Radiological Science and Technology, Department of Functional Brain Imaging, Japan)
[NFS-03-4]Progress in fluid biomarkers in neurodegenerative disorders
Takahiko Tokuda(National Institutes for Quantum Science and Technology, Japan)
[NFS-03-5]Progress in imaging biomarkers in neurodegenerative disorders
Hirohisa Watanabe(Department of Neurology, Fujita Health University, School of Medicine, Japan)
[NFS-03-6]Fluid biomarkers in prodromal Parkinson's disease
Takeshi Ikeuchi(Brain Research Institute, Niigata University, Japan)
[NFS-04-1]iPSCs-based Regenerative Therapy for Spinal Cord Injury
Hideyuki Okano(Keio University, Japan)
[NFS-04-2]Cellular transplantation therapy for toward ALS
Clive Svendsen(Board of Governors Regenerative Medicine Institute, USA)
[NFS-04-3]Mesenchymal stem cell therapy for Spinocerebellar degeneration
Chikafumi Yokoyama(REPROCELL Inc., Japan)
[NFS-04-4]Gene therapy in the field of experimental medicine of neurodegenerative diseases
Haruhisa Inoue(Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan)
[NFS-04-5]iPS cell-based therapy for Parkinson's disease
Jun Takahashi(Center for iPS Cell Research and Application, Japan)
[NFS-05-1]How does alpha-synuclein transfer from cell-to-cell?- The role of endosomal trafficking
Takafumi Hasegawa(Division of Neurology, Department of Neuroscience and Sensory Organs, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan)
[NFS-05-2]Mechanisms of the initiation of alpha synuclein aggregation and the propagation
Kensuke Ikenaka, Keita Kakuda, Cesar Aguirre, Choong Chi-Jing, Hideki Mochizuki(Osaka University Graduate School of Medicine, Japan)
[NFS-05-3]New mechanisms of toxicity from inside and outside of cells
Hitoshi Okazawa(Tokyo Medical and Dental University, Department of Neuropathology, Japan)
[NFS-05-4]Pathways of neuron demise in cerebellar ataxia and motor neuron demise: Leveraging insights from transcription dysregulation into novel therapy targets
Albert La Spada(University of California, Irvine, USA)
[HT-01-1]Multi-layer omics analysis elucidates biology of immune and infectious diseases
Yukinori Okada1,2,3(1.Dep. Genome Informatics, Graduate School of Medicine, the University of Tokyo, Japan, 2.Dep. Statistical Genetics, Osaka University Graduate School of Medicine, Japan, 3.ab. Systems Genetics, RIKEN Center for Integrative Medical Sciences, Japan)
[HT-01-2]Genome-wide association studies in multiple sclerosis and neuromyelitis optica spectrum disorder
Takuya Matsushita(Department of Neurology, Kochi Medical School, Kochi University, Japan)
[HT-01-3]Bioinformatics analysis in the research field of inflammatory CNS diseases
Makoto Kinoshita(Department of Neurology Osaka University Graduate School of Medicine, Japan)
[HT-01-4]A systems biology approach to MS and NMOSD by single cell sequencing of lymphocytes
Norio Chihara(Division of Neurology, Kobe University Graduate School of Medicine, Japan)
[HT-02-1]Overview of disease modifying treatment of progressive supranuclear palsy
Shinsuke Fujioka(Department of Neurology, Fukuoka University Faculty of Medicine, Japan)
[HT-02-2]Development of tau-directed therapies for progressive supranuclear palsy
Yasuo Toda(Japan Clinical Development and Pharmacology, Biogen Japan Ltd., Japan)
[HT-02-3]ARISE study: A Global Phase 2 trial of Tilavonemab in progressive supranuclear palsy
Nahome T. Fisseha(Japan Development, AbbVie GK, Japan)
[HT-02-4]Fluid biomarkers in primary tauopathies -Current status and future direction-
Kensaku Kasuga(Brain Research Institute, Niigata University, Japan)
[HT-02-5]CSF tau biomarkers in primary tauopathies
Chihiro Sato(Washington University School of Medicine, St. Louis, USA)
[HT-02-6]miR-6088 act as a potential diagnostic biomarker for Progressive Supranuclear Palsy
Hiroshi Takigawa1, Ryoishi Sakata1, Mayuko Sakuwa1, Tadashi Adachi2, Ritsuko Hanajima1(1.Division of Neurology, Department Brain and Neurosciences, Tottori University, Japan, 2.Division of Neuropathology, Department Brain and Neurosciences, Tottori University, Japan)
[HT-03-1]Stroke Consortium: Asia Pacific Stroke Organization (APSO)
Teruyuki Hirano(Department of Stroke and Cerebrovascular Medicine, Kyorin University, Japan)
[HT-03-2]Survey Findings on Parkinsons disease in Asia
Norlinah Mohamed Ibrahim1, Movement Disorders in Asia Study Group2(1.Faculty of Medicine, Universiti Kebangsaan Malaysia, Malaysia, 2.International Movement Disorders and Parkinson's Disease Society, USA)
[HT-03-3]PACTRIMS addresses challenges of multiple sclerosis and related disorders in Asia
Kazuo Fujihara1,2(1.Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan, 2.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Japan)
[HT-03-4]Updates of ALS research in PACTALS (Pan-Asian Consortium for the Treatment and Research in ALS)
Seung Hyun Kim1, PACTALS group2(1.Hanyang University Seoul Hospital, Korea, 2.PACTALS)
[HT-04-1]New and emerging medical therapies for epilepsy
Hiroshi Shigeto1,2(1.Division of Medical Technology, Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neurology, Kyushu University Hospital, Japan)
[HT-04-2]The state-of-the-art diagnosis and treatment of non-convulsive status epilepticus
Lawrence J. Hirsch(Comprehensive Epilepsy Center, Department of Neurology, Yale University, USA)
1,853 results ( 1 - 50 )
- 1
- ...